| Product Code: ETC9559989 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Multiple Myeloma Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Multiple Myeloma Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Multiple Myeloma Market - Industry Life Cycle |
3.4 Sweden Multiple Myeloma Market - Porter's Five Forces |
3.5 Sweden Multiple Myeloma Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Sweden Multiple Myeloma Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.7 Sweden Multiple Myeloma Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 Sweden Multiple Myeloma Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence and prevalence of multiple myeloma in Sweden |
4.2.2 Advances in medical technology leading to improved diagnosis and treatment options |
4.2.3 Growing healthcare expenditure and government initiatives to support cancer treatment |
4.3 Market Restraints |
4.3.1 High cost of multiple myeloma treatments and limited reimbursement options |
4.3.2 Stringent regulatory requirements for drug approvals and market access |
4.3.3 Limited awareness among the general population about multiple myeloma |
5 Sweden Multiple Myeloma Market Trends |
6 Sweden Multiple Myeloma Market, By Types |
6.1 Sweden Multiple Myeloma Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden Multiple Myeloma Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 Sweden Multiple Myeloma Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.1.4 Sweden Multiple Myeloma Market Revenues & Volume, By Protease Inhibitors, 2021- 2031F |
6.1.5 Sweden Multiple Myeloma Market Revenues & Volume, By Monocional Antbody, 2021- 2031F |
6.1.6 Sweden Multiple Myeloma Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Sweden Multiple Myeloma Market, By Disease Type |
6.2.1 Overview and Analysis |
6.2.2 Sweden Multiple Myeloma Market Revenues & Volume, By Active Multiple Myelom, 2021- 2031F |
6.2.3 Sweden Multiple Myeloma Market Revenues & Volume, By Smoldering Multiple Myeloma, 2021- 2031F |
6.3 Sweden Multiple Myeloma Market, By End user |
6.3.1 Overview and Analysis |
6.3.2 Sweden Multiple Myeloma Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Sweden Multiple Myeloma Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.4 Sweden Multiple Myeloma Market Revenues & Volume, By Other, 2021- 2031F |
7 Sweden Multiple Myeloma Market Import-Export Trade Statistics |
7.1 Sweden Multiple Myeloma Market Export to Major Countries |
7.2 Sweden Multiple Myeloma Market Imports from Major Countries |
8 Sweden Multiple Myeloma Market Key Performance Indicators |
8.1 Average time to diagnosis for multiple myeloma patients |
8.2 Number of clinical trials for new multiple myeloma treatments in Sweden |
8.3 Patient adherence to prescribed treatment regimens |
9 Sweden Multiple Myeloma Market - Opportunity Assessment |
9.1 Sweden Multiple Myeloma Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Sweden Multiple Myeloma Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.3 Sweden Multiple Myeloma Market Opportunity Assessment, By End user, 2021 & 2031F |
10 Sweden Multiple Myeloma Market - Competitive Landscape |
10.1 Sweden Multiple Myeloma Market Revenue Share, By Companies, 2024 |
10.2 Sweden Multiple Myeloma Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here